Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)

• Status: Completed
• Trial end date: 1989-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

To determine whether reduction of cholesterol by drug therapy significantly lowered the atherosclerotic coronary heart disease rate in a group of hypercholesterolemic but otherwise healthy men.

Total dollars spent on the CPPT from June 1973 were $142,250,000. We do not have a year-by-year breakdown.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Cholestyramine Resin

Criteria

Men, ages 35-59. Type II hyperlipoproteinemia. Free from coronary heart disease.